Kevin Chow
Corporate Officer/Principal bei ALSP ORCHID ACQUISITION CORPORATION I
Ursprung des Netzwerks ersten Grades von Kevin Chow
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.
38
| Holding Company | Investment Managers | 38 |
| Subsidiary | Pharmaceuticals: Major | 11 | |
| Private Company | Financial Conglomerates | 11 | |
Incisive Genetics, Inc.
 Incisive Genetics, Inc. BiotechnologyHealth Technology Incisive Genetics, Inc. is a privately held biotechnology company based in an undisclosed location, established in 2018. The Canadian company has developed a cutting-edge non-viral delivery platform for genetic therapies called Omnia™. This platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. The company was founded in 2018 by Blair R. Leavitt, Austin Hill, and Pamela Wagner. Blair R. Leavitt has been the CEO since 2018.
6
| Holding Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin Chow
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Miscellaneous Commercial Services | President Chief Executive Officer | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
| XENCOR, INC. | Biotechnology | Chairman Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Founder Doctorate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
WRF Capital
 WRF Capital Investment ManagersFinance WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Colorado State University | College/University | Undergraduate Degree Graduate Degree | |
| University of Iowa | College/University | Doctorate Degree Undergraduate Degree | |
| Washington State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Washington Biotechnology & Biomedical Association | Chairman Director/Board Member | ||
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Director/Board Member | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Founder Director/Board Member | |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Investment Managers | Investment Committee Member Investment Committee Member Investment Committee Member | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer Founder | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree | |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer Director/Board Member Private Equity Investor | |
| Life Science Washington | Director/Board Member Director/Board Member | ||
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Alexandria Agtech/Climate Innovation Acquisition Corp.
 Alexandria Agtech/Climate Innovation Acquisition Corp. Financial ConglomeratesFinance Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Lydian Neurosciences Corp.
 Lydian Neurosciences Corp. SemiconductorsElectronic Technology Lydian Neurosciences Corp. develops molecules for treatment. Le. The CEO of the American company is Thong Q. | Semiconductors | Chief Executive Officer Director/Board Member | |
Hc Bioscience, Inc.
 Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Chairman Founder |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 3 |
| Kanada | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 6 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 361 |
| Corporate Officer/Principal | 145 |
| Independent Dir/Board Member | 71 |
| Founder | 71 |
| Chief Executive Officer | 55 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Joel Marcus | 57 |
| Leroy Hood | 34 |
| Deepa Pakianathan | 32 |
| Thong Le | 30 |
| Peter Bisgaard | 28 |
| Bruce Carter | 25 |
| Aaron Davidson | 24 |
| Wendy Johnson | 23 |
| Sundar Kodiyalam | 21 |
| Jan Lundberg | 20 |
| Leslie Williams | 19 |
| Alan Montgomery | 18 |
| Paul Cleveland | 18 |
| Lee Babiss | 17 |
- Börse
- Insiders
- Kevin Chow
- Unternehmensverbindungen
